A randomized, double-blind, multinational trial comparing denosumab with zoledronic acid for treatment of bone disease in adults with newly diagnosed multiple myeloma.
Noopur S. Raje
Consultant or Advisory Role - Amgen
Evangelos Terpos
Consultant or Advisory Role - Amgen; Janssen-Cilag; MorphoSys
Honoraria - Celgene; Novartis
Research Funding - Amgen; Janssen-Cilag
Brian G. Durie
No relevant relationships to disclose
Ramon Garcia-Sanz
Honoraria - Amgen
Research Funding - Novartis
Kazuyuki Shimizu
Consultant or Advisory Role - Daiichi Sankyo
Honoraria - Daiichi Sankyo
Research Funding - Daiichi Sankyo
Expert Testimony - Amgen (U)
Wolfgang Willenbacher
Consultant or Advisory Role - Amgen
Honoraria - Amgen
Research Funding - Amgen
Li Zhu
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Ada H. Braun
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Rajul K. Jain
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Antonio Palumbo
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Millennium; Onyx
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Millennium; Onyx